Biocryst Pharmaceuticals (BCRX) Receivables - Other (2011 - 2013)

Biocryst Pharmaceuticals' Receivables - Other history runs 3 years deep, the most recent figure standing at $2.4 million for Q3 2013.

• Quarterly Receivables - Other fell 37.13% year-over-year to $2.4 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $2.4 million (down 37.13% YoY) and the FY2012 annual result came in at $4.6 million, down 21.76% from the prior year.
• Receivables - Other was $2.4 million for Q3 2013 at Biocryst Pharmaceuticals, up from $1.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $5.8 million in Q4 2011 and bottomed at $1.0 million in Q2 2013.
• A 3-year average of $3.9 million and a median of $4.3 million in 2013 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2012 — Receivables - Other slipped 21.76% — and 2013, when it slumped 79.86%.
• Biocryst Pharmaceuticals' Receivables - Other stood at $5.8 million in 2011, then decreased by 21.76% to $4.6 million in 2012, then slumped by 48.07% to $2.4 million in 2013.
• Business Quant data shows BCRX's Receivables - Other at $2.4 million in Q3 2013, $1.0 million in Q2 2013, and $4.3 million in Q1 2013.